What Medical Horizons does

Medical Horizons (legal name: Medical Horizons; Greek entity, headquartered at Faneromenis 30, 15562 Holargos, Athens, Greece) is a privately held, founder-owned medical device distribution and clinical services company founded in July 1996 by Konstantinos F. Velissarios. Operating with a 1-10 employee footprint, the firm functions as the exclusive Greek (and selective Cypriot) distributor for a portfolio of cardiovascular, endovascular, and intensive-care medical devices sourced from international manufacturers including CytoSorbents (CytoSorb cytokine adsorber), Coroneo (EXTRA-AORTIC Ring), Cryolife/Jotec (E-tegra, E-liac, E-nside, Nexus endografts and custom E-xtra Design manufacturing), Pie Medical Imaging (3mensio Vascular imaging software), PFM Medical (Multi-Snare Sets), Aferetica, and Medira (TRICENTO transcatheter tricuspid valve).

The company supplements device supply with hands-on clinical services: pre-operative CTA analysis, endovascular case planning, custom endograft design collaboration, physician training on device deployment, and 24/7 intraoperative clinical support for Greek cardiac surgery, vascular surgery, interventional radiology/cardiology, general surgery, and intensive care unit departments. Notable procedure milestones cited include the first E-nside endovascular implant in Cyprus and the Middle East at Aretaieion Hospital in March 2021.

Medical Horizons monetizes exclusively through hardware and consumable sales of distributed medical devices plus embedded clinical service fees; pricing is not publicly disclosed. The go-to-market is enterprise field sales — specialized medical representatives engage hospital departments directly, with a WeTransfer-based intake (medicalhorizons.wetransfer.com) for physician case submissions. The company holds ISO 9001:2015 and ISO 13485:2016 certifications, is compliant with the EU Medical Device Regulation (MDR), and maintains product marketing approvals from the Greek National Organization for Medicines (EOF) and registration with GEMI and the lists of Health Providers. It has not raised external funding, undergone M&A, or expanded headcount materially over its 25+ year operating history, signaling a stable but not high-growth distribution profile.

Name

Medical Horizons

Legal name

Medical Horizons

Website

https://medicalhorizons.gr

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Device Distribution

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)

Keywords

• Medical device distribution
• Cardiovascular medical devices
• Endovascular implants
• Cardiac surgery products
• Intensive care devices

Headquarters

HQ city

Kholargós

HQ country

Greece

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Medical Device Distribution: Distribution of proprietary medical devices including endovascular implants, cardiac valves, cytokine adsorbers, and imaging software. The company acts as exclusive Greek distributor for major international manufacturers.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Medical Horizons is an exclusive Greek distributor of cardiovascular and intensive care medical devices, supplying hospitals with CytoSorb cytokine adsorption therapy, endovascular aortic implants, percutaneous tricuspid valves (Tricento), aortic valve repair rings (EXTRA-AORTIC Ring), vascular imaging software, and endovascular accessories. The company complements device distribution with clinical support services including CTA analysis, case planning, custom endograft design, and 24/7 intraoperative assistance.

Product overview

Medical Horizons is a medical device distributor providing a portfolio of cardiovascular and intensive care products. The product lineup includes CytoSorb (extracorporeal cytokine adsorber for intensive care), Tricento (minimally invasive tricuspid valve replacement), EXTRA-AORTIC Ring (aortic valve repair system), 3mensio Vascular (angiography and CT analysis software), and Multi-Snare Sets. The company also provides clinical support services including CTA analysis, case planning, and technical assistance for endovascular procedures, covering cardiac surgery, vascular surgery, invasive radiology/cardiology, and intensive care sectors.

Differentiator

Problem solved

Functional benefit

Brands

• CytoSorb: Extracorporeal blood purification therapy system for reducing inflammatory mediators and treating cytokine storm conditions
• EXTRA-AORTIC Ring
• Tricento
• 3mensio Vascular

Products and services

• CytoSorb

Quantifiable outcome

• CytoSorb therapy used over 110,000 times worldwide
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Jotec GmbH (Germany)coreChannel Partner/ Reseller/ Distributor · 1 January 1996Exclusive Greek distributor for Jotec endovascular products including bifurcated and branched endografts (E-tegra, E-liac, E-nside, Nexus). The partnership enables Medical Horizons to provide comprehensive endovascular aortic treatment solutions.
• Cryolife Inc. (USA)coreChannel Partner/ Reseller/ Distributor · 1 January 1996Exclusive Greek distributor for Cryolife cardiovascular products. Cryolife acquired Jotec, expanding the product portfolio. Medical Horizons collaborates with Cryolife-Jotec's E-xtra Design department for custom endograft manufacturing.
• Coroneo (Canada)coreChannel Partner/ Reseller/ Distributor · 1 January 1996Exclusive Greek distributor for Coroneo's EXTRA-AORTIC Ring - a revolutionary extensible aortic ring for valve repair surgery. This partnership provides alternatives to full valve replacement.
• CytoSorbents (USA)coreChannel Partner/ Reseller/ Distributor · 1 January 1996Exclusive Greek distributor for CytoSorb cytokine adsorption therapy system. Used in over 110,000 treatments worldwide for managing cytokine storm and inflammatory response in ICU patients.
• Pie Medical Imaging (Netherlands)coreChannel Partner/ Reseller/ Distributor · 1 January 1996Exclusive Greek distributor for Pie Medical's 3mensio Vascular imaging software used for CTA analysis and case planning for endovascular procedures.
• AfereticaminorChannel Partner/ Reseller/ DistributorItalian medical device manufacturer represented by Medical Horizons in Greece. Products related to extracorporeal therapies.
• MediraminorChannel Partner/ Reseller/ DistributorMedical device manufacturer represented by Medical Horizons in Greece. Products featured on the Medical Horizons website.
• PFM MedicalminorChannel Partner/ Reseller/ DistributorGerman medical device manufacturer represented by Medical Horizons in Greece. Products include Multi-Snare Sets for endovascular procedures.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Others

• Cryolife Inc. Cryolife Inc. (which acquired Jotec) is the manufacturer Medical Horizons exclusively distributes in Greece and collaborates with on custom endograft design via the E-xtra Design department. Listed as OTHERS because it is a supplier/partner rather than a competitor, but its endovascular graft portfolio (E-tegra, E-liac, E-nside, Nexus) is the primary product line Medical Horizons sells.
• CytoSorbents Corporation: CytoSorbents is the manufacturer of the CytoSorb cytokine adsorber, a flagship ICU product line Medical Horizons exclusively distributes in Greece (>110,000 global treatments, 800+ departments). Listed as OTHERS because it is the upstream manufacturer/partner, but its therapy represents a significant share of Medical Horizons' ICU revenue base.
• Coroneo Inc. Coroneo is the Canadian manufacturer of the EXTRA-AORTIC Ring for valve repair surgery, exclusively distributed by Medical Horizons in Greece with 2,500+ implants globally. Listed as OTHERS because it is the manufacturer/partner; the device is a cornerstone of Medical Horizons' cardiac surgery product line.

Broad incumbents

• Edwards Lifesciences: Edwards Lifesciences is a global leader in heart valve therapies and hemodynamic monitoring, with a portfolio spanning surgical and transcatheter aortic, mitral, and tricuspid valve replacement/repair. It is a broad incumbent comparable because Medical Horizons distributes competing valve technologies (EXTRA-AORTIC Ring repair, TRICENTO transcatheter tricuspid) into the same cardiac surgery customer base.
• W. L. Gore & Associates: W. L. Gore & Associates manufactures the Gore Excluder and other flagship endovascular aortic repair (EVAR) grafts used widely in vascular surgery. Comparable as a broad incumbent because Gore's endograft line directly competes in the same EVAR/TEVAR procedure category Medical Horizons supports with Cryolife-Jotec and other products.
• B. Braun Melsungen: B. Braun is a large diversified medical device and pharmaceutical company with vascular access, interventional, and surgical specialty portfolios overlapping with several categories Medical Horizons distributes. Comparable as a broad incumbent operating in adjacent cardiovascular and interventional device markets.
• Boston Scientific: Boston Scientific operates major cardiology, structural heart, peripheral intervention, and endovascular franchises globally. Comparable as a broad incumbent because it fields alternative devices in many of the same procedural categories Medical Horizons supports, including aortic endovascular repair and interventional cardiology.
• Medtronic: Medtronic is a diversified medical device giant with extensive cardiovascular, cardiac surgery, endovascular, and structural heart franchises. It is a broad incumbent because its product breadth spans many of the same clinical categories Medical Horizons serves (vascular surgery, cardiac surgery, ICU-adjacent therapy) and competes indirectly for the same hospital wallet share.
• Terumo: Terumo is a global medical device manufacturer with a substantial interventional and cardiovascular portfolio, including endovascular, structural heart, and accessory devices used in the same vascular and cardiac surgery settings Medical Horizons serves. Comparable as a broad incumbent in overlapping procedural categories.
• Abbott: Abbott's cardiovascular and structural heart portfolios (including transcatheter valves and vascular devices) compete in the same endovascular and cardiac surgery markets Medical Horizons serves through its manufacturer partners. Comparable as a broad incumbent across multiple overlapping clinical indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medical-horizonsgr

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Horizons